North America Molecular Biology Enzymes, Kits, and Reagents Market Overview and Growth by 2028

The molecular biology enzymes, kits, and reagents market in North America is expected to grow from US$ 5,532.13 million in 2021 to US$ 17,999.75 million by 2028; it is estimated to grow at a CAGR of 18.4% from 2021 to 2028.

The outbreak of the COVID-19 pandemic situation shown some favorable scenario for players operating in the molecular biology enzymes, kits & reagents market. Various people across the North American region are affected with corona virus. For instance, the US is a highly affected country in the North American regions. The effect of the corona is mild in adults; however, it is adverse in older people. The infection of corona among older people has resulted in severe complications and has accounted for a good number of deaths in the country. But during the pandemic situation, life science companies engaged in development of novel drugs for the treatment of life threaten diseases. Therefore, molecular biology enzymes, kits & reagents products is required in drug design & development as well as COVID-19 diagnosis.

Furthermore, due to the rising numbers of COVID-19 population has positive impact on the molecular biology enzymes, kits & reagents market. In March 2021, Eurofins' Clinical Enterprise, Inc. has obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a direct-to-consumer (DTC) version of its EmpowerDX COVID-19 Home Collection Kit. The Eurofins at-home COVID-19 nasal PCR kit is one of the first over-the-counter SARS-CoV-2 at-home test kits approved by the European Union. Thus, rising numbers of product launches support the growth of the market. Similarly, in July 2020, Eurofins U.S. Clinical Diagnostics has announced the availability of its pooled PCR test to detect SARS-CoV-2, which would substantially lower the cost per PCR test for clients.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America molecular biology enzymes, kits, and reagents market. The North America molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.

North America Molecular Biology Enzymes, Kits, and Reagents Market Segmentation

North America Molecular Biology Enzymes, Kits, and Reagents Market – By Product

• Enzymes
  • Polymerases
  • Ligases
  • Reverse Transcriptases
  • Phosphatases
  • Proteases and Proteinases
  • Restriction Endonuclease
  • Other
• Kits and Reagents

North America Molecular Biology Enzymes, Kits, and Reagents Market – By Application

• Epigenetics
• Sequencing
• Synthetic Biology
• Polymerase Chain Reaction
• Other

North America Molecular Biology Enzymes, Kits, and Reagents Market – By End User

• Biotechnological and Pharmaceutical Companies
• Hospitals and Diagnostic Centres
• Academic and Research Institutes

North America Molecular Biology Enzymes, Kits, and Reagents Market, by Country

• US
• Canada
• Mexico

North America Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned

• Agilent Technologies, Inc.
• F. HOFFMANN-LA ROCHE LTD
• Illumina, Inc.
• Merck KGAA
• MERIDIAN BIOSCIENCE, INC
• Promega Corporation
• Qiagen
• Rockland Immunochemicals Inc 
• THERMO FISHER SCIENTIFIC INC

North America Molecular Biology Enzymes, Kits, and Reagents Report Scope